Write in a clean editor, then format for Neurology and Clinical Neuroscience in one click — DocuGuru applies the official Wiley template with author–year references and exports a submission-ready PDF plus the editable LaTeX source. Free to start.
Neurology and Clinical Neuroscience is a peer-reviewed journal published by Wiley, covering Parkinson's Disease Mechanisms and Treatments, Peripheral Neuropathies and Disorders, Neurological disorders and treatments.
| Publisher | Wiley |
|---|---|
| Reference style | Author–year (Chicago) Author–year — (Smith, 2023) in the text Smith, Ada, Ben Jones, and Cara Lee. 2023. "A Representative Article Title." Neurology and Clinical Neuroscience 12 (3): 45–58.
Formats any DOI in Neurology and Clinical Neuroscience style. No sign-up. |
| Publishes research in | Parkinson's Disease Mechanisms and Treatments Peripheral Neuropathies and Disorders Neurological disorders and treatments Genetic Neurodegenerative Diseases Autoimmune Neurological Disorders and Treatments |
| ISSN | 2049-4173 |
| Citation impact (2-yr) | 0.38 |
| h-index | 17 |
| i10-index | 60 |
| Total citations | 2,712 |
| Article processing charge | $2,730 |
| Top institutions publishing here | Okayama University |
| Journal website | onlinelibrary.wiley.com |
| You get | A submission-ready PDF and the editable LaTeX source — ready to submit. |
Citations each year’s papers have accumulated so far — the most recent years are still building up.
Abstract Aim Identification of sensitive surrogate markers that indicate disease progression in amyotrophic lateral sclerosis might be useful in clinical trials and clinical care. Determination of the creatinine/cystatin C (Cr/CysC) ratio eliminates the effect of renal function on serum creatinine levels; therefore, we considered that the ratio might serve as a surrogate marker of residual…
Abstract International Headache Society published the International Classification of Headache Disorders 2nd Edition (ICHD‐II) in 2004. In response to this development, the “Clinical Practice Guideline for Chronic Headache” was compiled in Japan by the Study Group for Chronic Headache Clinical Practice Guideline Development. In 2006, the book entitled “The Clinical Practice Guideline for Chronic Headache…
Abstract Background There are two formulations of levodopa in Japan and a few other countries, levodopa/benserazide 100/25 mg and levodopa/carbidopa 100/10 mg, which have been generally regarded as interchangeable in Parkinson's disease treatment. Aim We investigated the pharmacokinetics of levodopa in the two kinds of levodopa/decarboxylase inhibitor (benserazide or carbidopa) formulations to study their equivalence.…
Abstract Background We previously showed that zonisamide significantly improved parkinsonian symptoms by a multicenter, double‐blind clinical trial. Aim To confirm the efficacy of zonisamide on Parkinson's disease, a phase 3, randomized, placebo‐controlled, multicenter, double‐blind trial was carried out in Japan. Methods Participants had advanced Parkinson's disease taking L‐dopa with at least one other antiparkinson drug,…
Coronavirus disease 2019 (COVID-19) is a viral disease spread by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Because the recent pandemic has resulted in significant morbidity and mortality, understanding various aspects of this disease has become critical. SARS-CoV-2 can affect a variety of organs and systems in the body. The autonomic nervous system plays an…
